NANSIG’s 2nd journal club with Professor Rustam Al-Shahi Salman: Antiplatelet therapy after stroke due to intracerebral haemorrhage, the RESTART trial.
Time: April 30th 2020, 6pm
For NANSIG’s 2nd virtual journal club we’re delighted to be hosting Professor Rustam Al-Shahi Salman, the lead investigator for the RESTART trial. The RESTART trial was a randomized study which demonstrated that antiplatelet therapy following haemorrhagic stroke does not significantly increase the risk of recurrent intracerebral haemorrhage. This trial has had a significant impact on clinical practice and we are looking forward to hearing more about this work from Professor Salman.
The format will consist of a ~15/20 min presentation followed by a 15 min Q&A session.
Sign up link: https://docs.google.com/forms/d/e/1FAIpQLSdBt7wkIY75XtYiY7KnWhkuc0wjn8NU1KM6kULN6-pVE28u9w/viewform
The full paper can be found here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)30840-2/fulltext